I Cochereau-Massin

460 total citations
10 papers, 331 citations indexed

About

I Cochereau-Massin is a scholar working on Ophthalmology, Epidemiology and Pharmacology. According to data from OpenAlex, I Cochereau-Massin has authored 10 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 5 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in I Cochereau-Massin's work include Ocular Diseases and Behçet’s Syndrome (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Ocular Infections and Treatments (3 papers). I Cochereau-Massin is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (5 papers), Cytomegalovirus and herpesvirus research (4 papers) and Ocular Infections and Treatments (3 papers). I Cochereau-Massin collaborates with scholars based in France. I Cochereau-Massin's co-authors include Phuc LeHoang, M Robinet, Christine Katlama, M Gentilini, M Lautier-Frau, Patricia Marcel, Lydie Zazoun, Willy Rozenbaum, Sophie Matheron and Didier Ingrand and has published in prestigious journals such as Ophthalmology, Antimicrobial Agents and Chemotherapy and American Journal of Ophthalmology.

In The Last Decade

I Cochereau-Massin

10 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Cochereau-Massin France 8 232 188 48 41 31 10 331
M Robinet France 5 227 1.0× 248 1.3× 50 1.0× 51 1.2× 9 0.3× 8 330
Patricia Marcel France 6 240 1.0× 231 1.2× 50 1.0× 50 1.2× 7 0.2× 6 327
Lydie Zazoun France 6 277 1.2× 287 1.5× 56 1.2× 66 1.6× 4 0.1× 8 404
B. D. Kuppermann United States 5 227 1.0× 224 1.2× 12 0.3× 74 1.8× 6 0.2× 12 296
Jean D. Vaudaux Switzerland 10 201 0.9× 185 1.0× 121 2.5× 55 1.3× 6 0.2× 20 346
Marisa Flores-Aguilar United States 9 165 0.7× 218 1.2× 33 0.7× 27 0.7× 5 0.2× 17 312
Z. Timmerman Netherlands 5 152 0.7× 132 0.7× 207 4.3× 60 1.5× 5 0.2× 7 320
James M. Weisz United States 6 135 0.6× 57 0.3× 73 1.5× 19 0.5× 9 0.3× 7 224
S. M. Gordon United States 5 66 0.3× 390 2.1× 48 1.0× 72 1.8× 2 0.1× 6 428
Hassan Behboudi Iran 7 251 1.1× 74 0.4× 108 2.3× 30 0.7× 2 0.1× 26 370

Countries citing papers authored by I Cochereau-Massin

Since Specialization
Citations

This map shows the geographic impact of I Cochereau-Massin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Cochereau-Massin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Cochereau-Massin more than expected).

Fields of papers citing papers by I Cochereau-Massin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Cochereau-Massin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Cochereau-Massin. The network helps show where I Cochereau-Massin may publish in the future.

Co-authorship network of co-authors of I Cochereau-Massin

This figure shows the co-authorship network connecting the top 25 collaborators of I Cochereau-Massin. A scholar is included among the top collaborators of I Cochereau-Massin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Cochereau-Massin. I Cochereau-Massin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cochereau-Massin, I, J Bauchet, J M Vallois, et al.. (1994). Kinetics and tolerability of intravitreal pefloxacin in rabbits. Journal of Antimicrobial Chemotherapy. 33(2). 231–242. 9 indexed citations
2.
Cochereau-Massin, I, J Bauchet, Azzam Saleh‐Mghir, et al.. (1993). Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis. Antimicrobial Agents and Chemotherapy. 37(4). 633–636. 21 indexed citations
3.
Cochereau-Massin, I, Phuc LeHoang, M Lautier-Frau, et al.. (1992). Ocular Toxoplasmosis in Human Immunodeficiency Virus-infected Patients. American Journal of Ophthalmology. 114(2). 130–135. 72 indexed citations
4.
Cochereau-Massin, I, et al.. (1992). [Ocular prognosis in Behçet's disease].. PubMed. 15(5). 343–7. 31 indexed citations
5.
Cochereau-Massin, I, Alain Gaudric, Philippe Reinert, et al.. (1992). [Changes in the fundus in subacute sclerosing panencephalitis. Apropos of 23 cases].. PubMed. 15(4). 255–61. 16 indexed citations
6.
Katlama, Christine, Elisabeth Dohin, Éric Caumes, et al.. (1992). Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.. PubMed. 5 Suppl 1. S18–24. 21 indexed citations
7.
Cochereau-Massin, I, Phuc LeHoang, M Lautier-Frau, et al.. (1991). Efficacy and Tolerance of Intravitreal Ganciclovir in Cytomegalovirus Retinitis in Acquired Immune Deficiency Syndrome. Ophthalmology. 98(9). 1348–1355. 137 indexed citations
8.
Cochereau-Massin, I, et al.. (1991). [Syphilitic uveitis and human immunodeficiency virus infection].. PubMed. 14(11-12). 605–9. 2 indexed citations
9.
Cochereau-Massin, I, J Bauchet, F. Faurisson, et al.. (1991). Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits. Antimicrobial Agents and Chemotherapy. 35(6). 1112–1115. 17 indexed citations
10.
Cochereau-Massin, I, P. Le Hoang, M Lautier-Frau, et al.. (1990). [Cytomegalovirus retinitis in AIDS. Treatment with intravitreal injections of ganciclovir].. PubMed. 19(28). 1313–6. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026